Browse by Day Archive

Novo to pay up to $2.6 billion to China's Hengrui for rights to weight-loss pill

09/28/2026 10:46pm
Novo Nordisk will pay up to $2.6 billion to Jiangsu Hengrui Pharmaceuticals for the rights to an experimental weight-loss ​pill, expanding its pipeline through a second GLP-1 treatment deal with a Chinese partner.

Church of Jesus Christ unveils new Temple Square in general conference special

09/28/2026 6:47pm
The Salt Lake Temple has undergone extensive renovation, and so has Temple Square. A documentary on the project runs between sessions of general conference Sunday at noon.

AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up

09/28/2026 4:14pm
Summit Therapeutics said on Monday that British ​drugmaker AstraZeneca would invest $2 billion in the company and collaborate on a series of ‌studies testing their cancer treatments together.

Pennsylvania measles cases cross 900 as outbreak grows

09/28/2026 2:50pm
Pennsylvania's measles outbreak continued to worsen, with 68 new ​infections reported since Wednesday last week, bringing the total to 903 on Monday, health department ‌data showed, as the state grapples with the worst measles resurgence in ⁠decades.

Richard Paul Evans reveals inspiration behind his new book — and the struggle that shaped his life

09/28/2026 11:41am
Richard Paul Evans discusses the inspiration behind his new historical fiction novel, his struggles with Tourette syndrome and how those experiences have shaped his work.

Robert Hunter to be new UnitedHealthcare president

09/28/2026 11:16am
UnitedHealth executive Robert Hunter said ​in a LinkedIn post on Monday he would take ‌on the role of president of UnitedHealthcare, ⁠the company's ​insurance division.

ER doc comes to the rescue of his financially troubled peers

09/28/2026 10:01am
Jim Dahle was ticked off. Not incensed, exactly, but definitely perturbed.

Factbox-Major drugmakers turn to China for licensing deals

09/28/2026 8:39am
Novo Nordisk said on ​Tuesday it will pay up to $2.6 billion to Jiangsu ‌Hengrui Pharmaceuticals for the rights to an ⁠experimental weight-loss ​pill, making it ⁠the latest drugmaker to ‌license China-developed ‌medicines.

A national education survey ranks Utah dead last — and that's a good thing

09/28/2026 8:01am
It's good to be sitting atop the national poll for most things, but sometimes, being ranked dead last is the coveted spot. Such is the case for Utah in a new survey on student debt.

BioNTech to shutter three sites in Germany as no buyers emerge

09/28/2026 7:08am
(Removes erroneous reference to Singapore in first paragraph and ​headline)

Mirum's liver infection drug lowers virus levels in late-stage study

09/28/2026 6:46am
Mirum Pharmaceuticals on Monday said its experimental hepatitis ​drug reduced levels of the virus in patients, meeting the main goal of a late-stage study.

Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion

09/28/2026 5:41am
Merck said on Monday it would pay up ​to $2.13 billion under a global licensing deal with China's SciBrunch Therapeutics for rights to develop, ‌manufacture and sell an experimental cancer treatment.

Roche outlines plans to move towards autonomous AI labs

09/28/2026 5:05am
Swiss pharmaceutical giant Roche outlined plans to ​move towards autonomous AI labs to speed up research and development discovery at its pharma ‌investor day on Monday.